NCT00829933View on ClinicalTrials.gov

Late Phase 2 Study of DU-176b in Patients With Non-Valvular Atrial Fibrillation

PHASE2CompletedINTERVENTIONAL
Enrollment

536

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

July 31, 2008

Study Completion Date

September 30, 2008

Conditions
Atrial Fibrillation
Interventions
DRUG

DU-176b tablets

DU-176b tablets taken once daily for up to 12 weeks

DRUG

Warfarin potassium tablets

Warfarin potassium tablets taken once daily for up to 12 weeks

Trial Locations (1)

Unknown

Tokyo

Sponsors
All Listed Sponsors
lead

Daiichi Sankyo Co., Ltd.

INDUSTRY